Aline Pilon Mauricio da Silva, Isabela Ornelas Pereira, Tatianna Meireles D Alencar, Beatriz Brittes Kamiensky, Marihá Camelo Madeira de Moura, Francisco Álisson Paula de França, Thiago Cherem Morelli, Ana Roberta Pati Pascom
{"title":"巴西变性人和异装癖者接触前艾滋病预防的可及性：一项描述性研究，2018-2023","authors":"Aline Pilon Mauricio da Silva, Isabela Ornelas Pereira, Tatianna Meireles D Alencar, Beatriz Brittes Kamiensky, Marihá Camelo Madeira de Moura, Francisco Álisson Paula de França, Thiago Cherem Morelli, Ana Roberta Pati Pascom","doi":"10.1590/S2237-96222024v33e2024322.especial.en","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To analyze access to pre-exposure prophylaxis (PrEP) for HIV in Brazil, comparing transgender and cisgender populations.</p><p><strong>Methods: </strong>This was a descriptive study using data from the Medication Logistics Control System (Sistema de Controle Logístico de Medicamentos - SICLOM), related to the monitoring of PrEP between January 2018 and December 2023.</p><p><strong>Results: </strong>During the period analyzed, 149,022 people initiated PrEP, of whom 139,423 (94%) were cisgender and 9,599 (6%) were transgender. 54% cisgender and 46% transgender people were of White/Asian skin color, 67% cisgender and 48% transgender people had 12 or more years of study, and 40% cisgender and 52% transgender people were aged 15 to 29 years.</p><p><strong>Conclusion: </strong>The data showed disparities in access to PrEP, with the transgender population still underrepresented. Expanding targeted strategies may mitigate specific barriers faced by this population and promote greater equity in access to prophylaxis.</p>","PeriodicalId":51473,"journal":{"name":"Epidemiologia e Servicos de Saude","volume":"33 spe1","pages":"e2024322"},"PeriodicalIF":2.5000,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11734650/pdf/","citationCount":"0","resultStr":"{\"title\":\"Access of transgender people and transvestites to pre-exposure prophylaxis for HIV in Brazil: a descriptive study, 2018-2023.\",\"authors\":\"Aline Pilon Mauricio da Silva, Isabela Ornelas Pereira, Tatianna Meireles D Alencar, Beatriz Brittes Kamiensky, Marihá Camelo Madeira de Moura, Francisco Álisson Paula de França, Thiago Cherem Morelli, Ana Roberta Pati Pascom\",\"doi\":\"10.1590/S2237-96222024v33e2024322.especial.en\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>To analyze access to pre-exposure prophylaxis (PrEP) for HIV in Brazil, comparing transgender and cisgender populations.</p><p><strong>Methods: </strong>This was a descriptive study using data from the Medication Logistics Control System (Sistema de Controle Logístico de Medicamentos - SICLOM), related to the monitoring of PrEP between January 2018 and December 2023.</p><p><strong>Results: </strong>During the period analyzed, 149,022 people initiated PrEP, of whom 139,423 (94%) were cisgender and 9,599 (6%) were transgender. 54% cisgender and 46% transgender people were of White/Asian skin color, 67% cisgender and 48% transgender people had 12 or more years of study, and 40% cisgender and 52% transgender people were aged 15 to 29 years.</p><p><strong>Conclusion: </strong>The data showed disparities in access to PrEP, with the transgender population still underrepresented. Expanding targeted strategies may mitigate specific barriers faced by this population and promote greater equity in access to prophylaxis.</p>\",\"PeriodicalId\":51473,\"journal\":{\"name\":\"Epidemiologia e Servicos de Saude\",\"volume\":\"33 spe1\",\"pages\":\"e2024322\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-01-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11734650/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Epidemiologia e Servicos de Saude\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1590/S2237-96222024v33e2024322.especial.en\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"Multidisciplinary\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epidemiologia e Servicos de Saude","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1590/S2237-96222024v33e2024322.especial.en","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Multidisciplinary","Score":null,"Total":0}
引用次数: 0
摘要
目的：分析巴西艾滋病毒暴露前预防（PrEP）的可及性，比较跨性别人群和顺性别人群。方法：这是一项描述性研究，使用药物物流控制系统（Sistema de Controle Logístico de Medicamentos - SICLOM）的数据，与2018年1月至2023年12月期间PrEP的监测有关。结果：在分析期间，149,022人开始了PrEP，其中139,423人（94%）为顺性别，9,599人（6%）为变性人。54%的顺性别者和46%的跨性别者是白人/亚洲人肤色，67%的顺性别者和48%的跨性别者有12年以上的学习经历，40%的顺性别者和52%的跨性别者年龄在15至29岁之间。结论：数据显示PrEP的可及性存在差异，跨性别人群的代表性仍然不足。扩大有针对性的战略可以减轻这一人群面临的具体障碍，并促进在获得预防方面更加公平。
Access of transgender people and transvestites to pre-exposure prophylaxis for HIV in Brazil: a descriptive study, 2018-2023.
Objectives: To analyze access to pre-exposure prophylaxis (PrEP) for HIV in Brazil, comparing transgender and cisgender populations.
Methods: This was a descriptive study using data from the Medication Logistics Control System (Sistema de Controle Logístico de Medicamentos - SICLOM), related to the monitoring of PrEP between January 2018 and December 2023.
Results: During the period analyzed, 149,022 people initiated PrEP, of whom 139,423 (94%) were cisgender and 9,599 (6%) were transgender. 54% cisgender and 46% transgender people were of White/Asian skin color, 67% cisgender and 48% transgender people had 12 or more years of study, and 40% cisgender and 52% transgender people were aged 15 to 29 years.
Conclusion: The data showed disparities in access to PrEP, with the transgender population still underrepresented. Expanding targeted strategies may mitigate specific barriers faced by this population and promote greater equity in access to prophylaxis.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
